Copper-Iodide Antimicrobial Composition for Stable Biofilm Eradication

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current iodine-based antimicrobial solutions, such as PVP-I, face challenges in achieving a balance between effectiveness against pathogens and toxicity to healthy tissues, particularly in wound healing, and often require short application times and rinsing due to cytotoxicity concerns, while also struggling with stability and prolonged antimicrobial activity.

Innovation Solution

A stable antimicrobial composition comprising potassium iodide and copper sulfate in a carrier liquid, without buffers or surfactants, which generates a controlled amount of free iodine (100-330 ppm) and maintains stability and efficacy for extended periods, providing a non-toxic and non-irritating solution effective against a broad spectrum of pathogens and biofilms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If high levels of iodine are used in antiseptic preparations, then antimicrobial effectiveness is improved, but cytotoxicity and tissue irritation increase

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidcytotoxicity and tissue irritation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical form of iodine from elemental iodine (I2) to iodide ions (I-) through reaction with copper sulfate, fundamentally altering the chemical parameters of the iodine compound. This transformation maintains antimicrobial effectiveness while reducing cytotoxicity, as the iodide-copper complex provides controlled iodine release without the harsh effects of high-concentration elemental iodine

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Copper sulfate acts as an intermediary substance that reacts with potassium iodide to generate iodine in situ. The copper ions (Cu2+) mediate the conversion of iodide to elemental iodine, providing a controlled release mechanism that maintains effective iodine levels for pathogen killing while avoiding the need to apply high concentrations of free iodine that would cause tissue damage

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If PVP-I is used to disinfect surgical sites, then antimicrobial activity is achieved, but wound healing is delayed due to cytotoxic effects

Engineering Contradiction:
Improveantimicrobial activityVSAvoidwound healing time
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent changes the chemical formulation from povidone-iodine complex to a copper-mediated iodide system. This parameter change in chemical composition fundamentally alters the toxicity profile, allowing the solution to remain on wounds for extended periods (24 hours or more) without delaying healing, while maintaining antimicrobial activity throughout this extended duration

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The copper-iodide system provides sustained, continuous antimicrobial action over 24 hours or longer without requiring rinsing or reapplication. The controlled release of iodine from the copper complex maintains effective concentrations continuously, eliminating the need for short application times followed by flushing that characterizes PVP-I use

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If conventional iodine solutions are applied to wounds, then pathogen killing is achieved, but the solution loses stability and efficacy over time

Engineering Contradiction:
Improvepathogen killing effectivenessVSAvoidsolution stability duration
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent extracts the instability element (free elemental iodine) from the formulation and replaces it with a stable copper-iodide complex system. By removing free iodine and using copper ions to control iodine release, the solution achieves long-term stability while maintaining pathogen-killing effectiveness throughout the extended contact period

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a composite chemical system combining copper sulfate and potassium iodide that work synergistically. The copper-iodide complex provides both stability and sustained antimicrobial activity, with the composite formulation maintaining efficacy for 24 hours or more without the degradation issues of conventional iodine solutions

Inventive Principle:
Principle #40Composite materials

4Object-affected harmful factors

If short application time with rinsing is used for PVP-I, then cytotoxicity is reduced, but prolonged antimicrobial activity is compromised

Engineering Contradiction:
ImprovecytotoxicityVSAvoidantimicrobial activity duration
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of moving object

Solution Approach 1:

The copper-iodide system enables continuous antimicrobial action over 24 hours or longer without requiring removal by rinsing. The controlled release of iodine from the copper complex maintains effective concentrations continuously, providing prolonged protection without the cytotoxicity concerns that necessitate rinsing of PVP-I

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

Copper ions serve as an intermediary that controls the release rate of active iodine, creating a sustained-release effect. This mediator mechanism allows the solution to remain on tissue for extended periods, providing continuous antimicrobial activity without the peak concentration spikes that cause cytotoxicity in conventional formulations

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition demonstrates sustained antimicrobial activity for 24 hours or more with a greater than 4 log kill rate against pathogens, including ESKAPE pathogens, and remains stable for at least 12 months without precipitation or loss of efficacy, effectively treating wounds and preventing infections while being safe for prolonged contact with skin and tissues.

Implementation Method 1

A stable antimicrobial composition comprising potassium iodide and copper sulfate in a carrier liquid, without buffers or surfactants, which generates a controlled amount of free iodine (100-330 ppm)

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Data Source

PatentUS20230389553A1Disinfectants with iodine and copper complexes for biofilm eradication and prevention
Publication Date: 2023.12.07 CLYRA MEDICAL TECHNOLOGIES INC
  • US20230389553A1 patent drawing
  • US20230389553A1 patent drawing
  • US20230389553A1 patent drawing

AI summary

Stable antimicrobial compositions for disinfection are disclosed. Such disinfectant compositions are highly effective in reducing, preventing and/or eradicating biofilm formation and other prevalent pathogens, have extended antimicrobial and antiviral activity for more than 24 hours, have a bio-compatible pH, are suitable for personal, clinical and surgical use and are safe to skin, mucous membranes and wounds, remain stable without precipitation, discoloration or loss of antimicrobial efficacy for at least 12 months, and are beneficial for a range of applications and uses in improving and supporting human and animal health.